A brief outline of drug integrated polymer fibers market with respect to the application spectrum: global industry valuation to exceed USD 88 billion by 2025
Publisher : Fractovia | Published Date : 2019-03-11Request Sample
The drug integrated polymer fibers market is experiencing a transformational shift in dynamics in the recent times across the world owing to an increase in improved healthcare facilities in developing economies coupled with the rising population. The advancement in technologies in medical textile engineering as well as the growing implantable medical surgeries have led to an upsurge in the demand for these polymeric fibers. Furthermore, the healthcare industry is fraught with numerous research and development programs for replacing traditional materials with innovative biomaterials, that will also notably boost the drug integrated polymer fibers industry over 2019-2025.
U.S. Drug Integrated Polymer Fibers market, by application, 2014 - 2025 (USD Million)
The global market outlook will also witness a change on account of the surge in innovative materials for orthopedics across the globe. The rising old age population, particularly in North America and Europe, is also a crucial factor that will propel the growth of this industry in the upcoming years. Drug integrated polymer fibers are utilized in creating implantable textile devices deploying a combination of non-resorbable as well as resorbable polymers. These devices could be produced from various materials and are available in custom shapes and sizes for meeting precise biological requirements. With an increase in complexity as well as technological innovations, textile devices are now being designed for meeting a wider range of applications than earlier, which would in turn escalate drug integrated polymer fibers industry share over 2019-2025.
The capability of drug integrated polymer fibers has proved to be highly useful across a series of end-use verticals, expanding stretching the application scope of this industry, a gist of which is given below:
Unveiling drug integrated polymer fibers market trends from drug delivery applications:
The drug delivery sector is confined to come up as a chief application avenue for drug integrated polymer fibers market. The product is largely deployed across the drug delivery and biopharmaceutical industry. Owing to the huge demand for medicine and drug across a slew of domains, the global drug delivery sector is market to showcase a huge upsurge in terms of revenue in the coming years. It is thus quite vivid that this would reshape the commercialization graph of the global drug integrated polymer fibers market from drug delivery application.
Speaking of one of the innovations in drug delivery technology, biotech company Halozyme recently licensed its drug delivery technology to Roche. The Enhanze technology from Halozyme Inc., degrades a chain of natural sugars in the body for some time, which helps in the absorption and dispersion of injected therapeutic drugs. Halozyme further said that this form of delivery might enable absorption of higher efficiency via subcutaneous administration, along with reducing the requirement of multiple injections. With such advancements in the drug delivery sector, it is overt that the industry will depict promising growing in the future, which will simultaneously augment the drug integrated polymer fibers market over 2019-2025.
Unveiling drug integrated polymer fibers market trends from dermal wound healing applications:
The dermal wound healing sector is expected to be a viable revenue stream for drug integrated polymer fibers market, due to the product demand across healthcare institutions. The robust expansion of healthcare facilities across the globe and the developments prevalent in medical fraternity will thus prove to be a crucial growth impetus for this industry.
Data from the American Society of Plastic Surgeons (ASPS) shows a continued growth in cosmetic procedures over the previous year. As per the statistics from the American Society of Plastic Surgeons, around 17.5 million minimally invasive cosmetic and surgical procedures were conducted in the U.S. in 2017 – a near-about 2% increase over 2016. The statistics also revealed that Americans are inclined towards innovative ways for shaping their bodies, due to which the minimally invasive cosmetic procedures have depicted an increase of nearly 200% since 2000. The growing prevalence of cosmetic and surgical procedures would thus drive the dermal wound healing sector, which would result in the growth of drug integrated polymer fibers market in the forthcoming years.
Backed by a wide application spectrum, the drug integrated polymer fibers market will amass renewed traction in the coming years. For the record, the drug integrated polymer fibers market size is estimated to surpass a colossal of US$88.8 million by the end of 2025.
